To identify the prognostic relevance of PSMA, we performed a systematic analysis of a comprehensive NSCLC study cohort (n = 275) with focus on the PSMA expression in both neovascular and tumor cells. The gene discussed is FOLH1; the disease is non-small cell lung carcinoma.